Want to see CHCT full AI Analyst Report?
Community Healthcare (CHCT) Q2 2026 Earnings Report
CHCT Q2 2026 EPS Results
- Actual EPS
- $0.06
- Consensus EPS
- $0.11
- Beat/Miss
- Missed by -$0.05
- One Year Ago EPS
- -$0.50
CHCT Q2 2026 Revenue Results
- Actual Revenue
- $31.22M
- Expected Revenue
- $31.77M
- Beat/Miss
- Missed by -$544.00K
- YoY Revenue Growth
- +7.35%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/04/2026
- Time
- After Close
- Conference Call
- Tuesday, August 4, 2026
Community Healthcare's next earnings date is estimated for November 3, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
The call presents a constructive and proactive strategic reset: management implemented a material dividend reduction to retain capital, launched clearer disclosure and recycling initiatives, and outlined a multi-pronged plan (occupancy improvement, redeployment, dispositions and acquisitions) with concrete targets and yield expectations. Near-term negatives include a sizable dividend cut, flat AFFO per share quarter-over-quarter, prior reduced acquisition cadence and execution risk around the behavioral health transaction. However, leasing momentum, defined acquisition targets for 2026, visible disposition proceeds and attractive redevelopment yields provide a credible path to accelerate AFFO and portfolio quality, leading management to portray confidence in achieving the plan.
Management guided a clear capital‑reallocation plan: they right‑sized the quarterly dividend from $0.48 to $0.33 (dividend to be reviewed annually), which will free $25–$30 million over the next two years (≈up to $15M/year); on a leverage‑neutral basis (~40% debt-to-capitalization) that can fund ≈$25M/year of incremental acquisitions/reinvestment and drive $0.06–$0.07 of incremental AFFO per year assuming 9–10% yields, while targeting a 60–65% AFFO payout ratio and maintaining current target leverage. Operational targets include a 70‑bp occupancy improvement to 90.5% by year‑end 2026 with a path to ~92% within ~18 months (up to $6M NOI upside), redeploying into projects with 9–12% yields on cost, continuing strategic capital recycling (7 properties sold for $38.5M net proceeds; >$70M of assets in market), and stepping up acquisitions to $85–$90M in 2026 (after $64.5M and $72.1M in the prior two years) plus four signed deals aggregating ~$99M (expected returns 9.1%–9.75%) with scheduled closings in Q3/Q4 2026 and H2 2027; Q2 financials cited: revenue $31.2M, property operating expenses $5.9M, G&A $4.9M, interest $7.4M, FFO $13.2M ($0.48/sh), AFFO $15.4M ($0.56/sh).
- Dividend Rightsizing Frees Capital for GrowthQuarterly dividend reduced from $0.48 to $0.33 per share (‑31.25%), expected to retain $25M to $30M over the next 2 years (up to ~$15M per year) to fund accretive acquisitions and reinvestment.
- Clear Strategic Plan and Four PrioritiesCompany articulated four core priorities — occupancy improvement, portfolio reinvestment, strategic capital recycling and accelerated acquisition growth — intended to drive AFFO growth and portfolio quality.
- Occupancy Momentum and TargetYear-to-date leasing signed >100,000 sq ft (surpassing total 2025 volume); 2026 leasing budget targets a 70 bps increase to 90.5% by year-end and management expects to reach ~92% occupancy within ~18 months (targeted end of 2027).
- NOI and AFFO Upside from Occupancy and LeasingManagement estimates full realization of occupancy gains and rent growth could represent up to $6M of incremental NOI; retained cash flow projected to generate incremental $0.06–$0.07 of AFFO growth per year assuming 9%–10% yield.
- Capital Recycling and Disposition ProceedsSince launch of recycling initiative, sold 7 properties generating $38.5M net proceeds; >$70M of assets currently marketed to fund higher-yield acquisitions.
- Planned Increase in Acquisition ActivityCompany expects to close $85M–$90M of acquisitions in 2026 (up from $64.5M and $72.1M in the prior two years), enabling an increased acquisition cadence into 2027.
- Redevelopment and Spec Buildouts with Attractive YieldsTargeted redevelopment projects and speculative suite buildouts projected to yield 9%–12% on cost; four signed purchase-and-sale agreements expected to invest ~$99M with anticipated returns of 9.1%–9.75%.
- Steady AFFO and Added Financial TransparencyAFFO for Q2 2026 was $15.4M or $0.56 per diluted share (unchanged from Q1 2026; 0% QoQ change). Company expanded supplemental disclosures (FAD calculation, portfolio breakdowns) to improve investor transparency.
- Progress on Behavioral Hospital Operator TransitionGeriatric Behavioral Hospital operator paid ~$370K in rent in Q2 (+$70K QoQ; +23.3% vs Q1). Buyer progressing through diligence and drafting purchase agreements; management anticipates signed purchase agreement in Q3 and potential close by year-end (subject to documentation/closing conditions).
CHCT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 03, 2026 | 2026 (Q3) | 0.09- | 0.03 | ― | ― |
| Aug 04, 2026 | 2026 (Q2) | 0.110.06 | -0.5 | 112.00% (+0.56) | |
| May 05, 2026 | 2026 (Q1) | ―0.07 | 0.03 | 133.33% (+0.04) | |
| Feb 17, 2026 | 2025 (Q4) | 0.110.51 | 0.04 | 1175.00% (+0.47) | |
| Oct 28, 2025 | 2025 (Q3) | 0.080.03 | 0.04 | -25.00% (-0.01) | |
| Jul 29, 2025 | 2025 (Q2) | -0.13-0.50 | -0.42 | -19.05% (-0.08) | |
| Apr 29, 2025 | 2025 (Q1) | 0.070.03 | 0.11 | -72.73% (-0.08) | |
| Feb 18, 2025 | 2024 (Q4) | 0.070.04 | 0.15 | -73.33% (-0.11) | |
| Oct 29, 2024 | 2024 (Q3) | 0.070.04 | 0.11 | -63.64% (-0.07) | |
| Jul 30, 2024 | 2024 (Q2) | 0.15-0.42 | 0.24 | -275.00% (-0.66) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

